Two cancer immunotherapy makers face different situations in reimbursement talks

18 July 2019 - MSD returns to renegotiation table; BMS suffers from partner’s silence. ...

Read more →

LifeMax receives rare paediatric disease designation for LM-030 for the treatment of Netherton syndrome

18 July 2019 - LifeMax Laboratories today announced that the FDA granted rare paediatric disease designation to LM-030, an investigational therapy ...

Read more →

On drug prices, Trump must resist left-wing approaches that would lead to disaster

17 July 2019 - In Friday's column, I explained why President Donald Trump and the Republicans are on their way ...

Read more →

Car shopping, handbags and wealthy uncles: the quest to explain high drug prices

17 July 2019 - High drug prices are a hot topic in politics right now. President Trump has made lowering ...

Read more →

Durect announces that the FDA agreed to file the full response to the Posimir complete response letter as a complete Class 2 resubmission

17 July 2019 - User fee goal date is 27 December 2019. ...

Read more →

U.S. FDA accepts Allergan's new drug application for bimatoprost sustained release in patients with open-angle glaucoma or ocular hypertension

17 July 2019 - Filing included data from the Phase 3 ARTEMIS studies, which demonstrated that the majority of patients remained ...

Read more →

FDA approves Merck’s Recarbrio (imipenem, cilastatin, and relebactam) for the treatment of adults with complicated urinary tract and complicated intra-abdominal bacterial infections where limited or no alternative treatment options are available

17 July 2019 - Merck  today announced that the U.S. FDA has approved Recarbrio (imipenem, cilastatin, and relebactam) for injection, 1.25 ...

Read more →

Kamala Harris introduces plan to lower prescription drug prices

16 July 2019 - Senator Kamala Harris unveiled a plan Tuesday to lower prescription drug prices if she's elected president. ...

Read more →

Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

Drug Utilisation Sub-Committee outcome statement

17 July 2019 - The outcome statement from the June 2019 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

Knight Therapeutics announces Health Canada has approved Nerlynx for early-stage breast cancer

16 July 2019 - Knight Therapeutics announced today that Health Canada has approved Nerlynx (neratinib) for the extended adjuvant treatment of ...

Read more →

How pharma, under attack from all sides, keeps winning in Washington

16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...

Read more →

Price increases of protected-class drugs in Medicare Part D, relative to inflation, 2012-2017

16 July 2019 - In recent years, the Centers for Medicare & Medicaid Services has considered allowing greater flexibility in ...

Read more →

National regulator denied offer to give Canadian physicians training on abortion pill

16 July 2019 - The group representing Canada’s family doctors turned down an offer from a national abortion group to ...

Read more →

Ask whether a drug works before worrying about what it costs

16 July 2019 - Last week was supposed to be a turning point for drug price transparency.  ...

Read more →